Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
Pashna N MunshiDavid VesoleArtur JurczyszynJan Maciej ZauchaAndrew St MartinOmar DavilaVaibhav AgrawalSherif M BadawyMinoo BattiwallaSaurabh ChhabraEdward CopelanMohamed A Kharfan-DabajaNosha FarhadfarSiddhartha GangulyShahrukh K. HashmiMaxwell M KremHillard M LazarusEhsan MalekKenneth MeehanHemant S MurthyTaiga NishihoriRebecca L OlinRichard F OlssonJeffrey SchriberSachiko SeoGunjan ShahMelhem SolhJason TayShaji K KumarMuzaffar H QazilbashNina ShahParameswaran N HariAnita D SouzaPublished in: Cancer (2020)
The results of the current study demonstrated that AHCT remains an effective consolidation therapy among patients with MM across all age groups.